Tag: closed system transfer devices market forecast

  • Closed System Transfer Devices Market Expansion Is Opening New Pathways For Strategic Investment

    Closed System Transfer Devices Market Expansion Is Opening New Pathways For Strategic Investment

    Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

    The closed system transfer devices market is experiencing significant growth driven by rising healthcare needs and safety concerns. As regulations tighten and cancer cases increase globally, the demand for safer drug handling solutions continues to accelerate. This overview explores the market size, key growth drivers, leading companies, and future trends shaping this vital healthcare segment.

    Market Size and Projected Growth in the Closed System Transfer Devices Market

    The closed system transfer devices market has seen rapid expansion in recent years. Valued at $1.18 billion in 2025, it is expected to grow to $1.35 billion in 2026, reflecting a compound annual growth rate (CAGR) of 14.2%. This growth during the historical period has been fueled by the increasing use of hazardous drugs in oncology, heightened awareness about occupational exposure risks, stringent safety guidelines for drug handling, the growth of hospital oncology services, and wider adoption of chemotherapy infusion therapies. Looking ahead, the market is forecasted to reach $2.18 billion by 2030, with a slightly moderated CAGR of 12.6%. Factors contributing to this projected surge include stricter regulatory enforcement related to hazardous drug handling, rising volumes of cancer treatments, enhanced emphasis on workplace safety compliance, global expansion of oncology centers, and increased investment in hospital pharmacy safety infrastructure. Important trends during this period feature broader adoption of closed drug handling systems in oncology, heightened focus on healthcare worker safety, growing preference for needleless closed transfer devices, wider use in hospital pharmacies, and greater standardization of hazardous drug protocols.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

    Key Factors Propelling Growth in the Closed System Transfer Devices Market

    The rising incidence of cancer worldwide is a primary driver of the closed system transfer devices market. Cancer involves the uncontrolled growth and spread of abnormal cells that can invade tissues and metastasize through blood and lymphatic systems. Various factors, such as lifestyle habits, environmental exposures, and infectious agents, contribute to the growing number of cancer cases globally. Closed system transfer devices play an essential role in cancer treatment by protecting healthcare professionals and patients from exposure to hazardous chemotherapy drugs. Their use ensures safer environments in healthcare settings and supports improved treatment outcomes. For example, the World Health Organization (WHO) reported in February 2024 that cancer cases are expected to exceed 35 million by 2050, marking a 77% increase from the estimated 20 million cases projected for 2022. This sharp rise highlights the increasing global burden of cancer.

    Additional Evidence of Cancer’s Impact on Market Demand

    In the United States alone, the National Center for Biotechnology Information (NCBI) projected in January 2023 that there would be 1,958,310 new cancer cases diagnosed and 609,820 cancer-related deaths in 2023. These statistics underscore the substantial need for effective safety measures in cancer treatment, further boosting demand for closed system transfer devices. As cancer cases climb, the necessity for such protective technologies continues to grow, driving ongoing market expansion.

    Access The Complete Closed System Transfer Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

    Market Segments Dominating the Closed System Transfer Devices Industry

    This market is segmented by multiple factors to provide detailed insights into product categories and end users:

    1) By Type: Needleless Systems and Membrane-To-Membrane Systems

    2) By Technology: Diaphragm-Based, Compartmentalized, and Filtration technologies

    3) By Closing Mechanism: Color-To-Color Alignment, Push-To-Turn, Click-To-Lock, and Luer-Lock systems

    4) By End User: Hospitals and Clinics, Oncology Centers, and Other End Users

    Further breakdown includes subsegments such as Needleless Systems comprising Closed Vial Systems, Closed Syringe Systems, and Transfer Device Adapters, while Membrane-To-Membrane Systems include Membrane-To-Membrane Transfer Devices and Filtered Membrane Transfer Devices.

    Innovative Developments Defining the Future of the Closed System Transfer Devices Market

    Leading players in the closed system transfer devices market are prioritizing innovation to enhance safety and usability while meeting stringent healthcare regulations. For instance, syringe units designed for full volume use—meaning they deliver the complete dose without requiring additional mixing—are gaining attention. In October 2023, Equashield, a US-based medical device firm, introduced the EQUASHIELD Syringe Unit, which received FDA clearance for full-volume application. This product prevents vapor escape and contamination of the plunger, offering a safer, more efficient, and cost-effective solution for compounding and administering hazardous drugs.

    Key Players Shaping the Competitive Landscape in the Closed System Transfer Devices Market

    Numerous prominent companies are actively competing in this market, including:

    Cardinal Health Inc., Becton Dickinson and Company, Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Aegis Medical Technologies, Epic Medical Pte Ltd., and Smiths Medical.

    Regional Market Dynamics and Growth Opportunities in the Closed System Transfer Devices Market

    In 2025, North America accounted for the largest share of the closed system transfer devices market. However, the Asia-Pacific region is anticipated to exhibit the fastest growth rate over the forecast period. The market analysis covers key regions, including Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a comprehensive perspective on global market trends and opportunities.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Rising Cancer Incidence Fueling Growth in the Closed System Transfer Devices Market Is Supporting Development Across The Closed System Transfer Devices Market

    Rising Cancer Incidence Fueling Growth in the Closed System Transfer Devices Market Is Supporting Development Across The Closed System Transfer Devices Market

    The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

    How Will The Market Size Of The Closed System Transfer Devices Market Progress Through 2030?

    The closed system transfer devices market has expanded quickly over recent years. Its value is anticipated to rise from $1.18 billion in 2025 to $1.35 billion in 2026, at a compound annual growth rate (CAGR) of 14.2%. Historically, this growth has been driven by the increasing application of hazardous drugs in oncology, greater awareness of occupational exposure risks, the implementation of safety guidelines for drug handling, the expansion of hospital oncology services, and the growing adoption of chemotherapy infusion therapies.

    The market for closed system transfer devices is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $2.18 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. Factors driving this growth during the forecast period include more stringent regulatory enforcement concerning the handling of hazardous drugs, an increase in cancer treatment volumes, a heightened focus on adherence to workplace safety, the global expansion of oncology centers, and increased financial commitments to hospital pharmacy safety infrastructure. Key trends observed within this period encompass the growing integration of closed drug handling systems within oncology, an intensified concentration on safeguarding healthcare workers and minimizing their exposure, a surging preference for needleless closed transfer systems, the broader implementation of CSTD across hospital pharmacies, and an enhanced standardization of protocols for handling hazardous drugs.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

    Which Growth Drivers Are Expected To Support The Closed System Transfer Devices Market Forward?

    The rising incidence of cancer is anticipated to fuel the expansion of the closed-system transfer devices market in the future. This illness involves the unchecked multiplication of abnormal cells, which are capable of infiltrating adjacent tissues and migrating to other areas of the body via the bloodstream and lymphatic systems. The growing number of cancer cases stems from multiple contributors, including lifestyle choices, environmental influences, and heightened infection rates. In cancer therapy, closed-system transfer devices serve as crucial instruments, safeguarding both healthcare professionals and patients from hazards linked to the handling and delivery of chemotherapy medications. These devices foster a more secure healthcare setting and lead to improved treatment results for individuals with cancer. For example, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported in February 2024 that cancer cases are projected to surpass 35 million by 2050, marking a 77% surge from the approximately 20 million cases estimated for 2022. This considerable increase underscores the escalating global impact of cancer. Additionally, the National Center for Biotechnology Information, a US-based intergovernmental organization, stated in January 2023 that the United States anticipated 1,958,310 new cancer cases and 609,820 cancer deaths in 2023. Consequently, the escalating number of cancer cases acts as a key driver for the closed system transfer devices market.

    What Segment Categories Are Evaluated In The Closed System Transfer Devices Market Study?

    The closed system transfer devices market covered in this report is segmented –

    1) By Type: Needleless Systems, Membrane-To-Membrane Systems

    2) By Technology: Diaphragm-Based, Compartmentalized, Filtration

    3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems

    4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

    Subsegments:

    1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters

    2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

    What Trends Are Shaping The Closed System Transfer Devices Market Structure?

    Leading companies in the closed system transfer devices (CSTD) market are concentrating on developing advanced syringe units to boost safety, improve user experience, decrease contamination risks, and meet strict regulatory standards within the healthcare sector. A syringe unit for full volume use signifies a syringe engineered to dispense or administer the entire quantity of liquid or medication it holds, without requiring additional mixing or dilution. For example, in October 2023, Equashield, a US-based medical device company, introduced the EQUASHIELD Syringe Unit, which has secured FDA clearance for full-volume use, facilitating safer and more efficient handling of hazardous drugs. This innovative design prevents vapor escape and plunger contamination, positioning it as an economical solution for compounding and administering medications.

    Which Organizations Are Involved In The Closed System Transfer Devices Market?

    Major companies operating in the closed system transfer devices market are Cardinal Health Inc., Becton Dickinson and Company, Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Aegis Medical Technologies, Epic Medical Pte Ltd., Smiths Medical

    Access The Complete Closed System Transfer Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

    Which Regional Market Leads The Closed System Transfer Devices Market?

    North America was the largest region in the closed system transfer device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access a Customized Closed System Transfer Devices Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp

    Browse Through More Reports Similar to the Global Closed System Transfer Devices Market 2026, By The Business Research Company

    White Biotechnology Market Report 2026

    https://www.thebusinessresearchcompany.com/report/white-biotechnology-global-market-report

    Pet Cloning Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pet-cloning-global-market-report

    Synthetic Biology Market Report 2026

    https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Closed System Transfer Devices Market Future Outlook Showing Growth Toward $2.17 Billion By 2030

    Closed System Transfer Devices Market Future Outlook Showing Growth Toward $2.17 Billion By 2030

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Expansion In Market Value Is Forecasted For The Closed System Transfer Devices Market Between 2026 And 2030?

    The market size for closed system transfer devices has seen rapid expansion in recent years. This market is forecast to increase from $1.18 billion in 2025 to $1.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.2%. The growth observed in the historical period is linked to the rising use of hazardous drugs in oncology, increased awareness of occupational exposure risks, the establishment of safety guidelines for drug handling, the expansion of hospital oncology services, and the growing adoption of chemotherapy infusion therapies.

    The market for closed system transfer devices is projected to experience swift expansion in the coming years. This market is anticipated to reach $2.18 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. The projected expansion during this period stems from factors such as more stringent regulatory enforcement regarding hazardous drug handling, an increase in cancer treatment volumes, a greater focus on adherence to workplace safety, the worldwide proliferation of oncology centers, and increased capital expenditure in hospital pharmacy safety infrastructure. Key trends expected during the forecast period encompass the increasing integration of closed drug handling systems in oncology, an elevated focus on protecting healthcare workers and minimizing their exposure, a growing inclination towards needleless closed transfer systems, the broader implementation of CSTD across hospital pharmacies, and the increasing standardization of protocols for handling hazardous drugs.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

    Which Key Drivers Are Affecting The Closed System Transfer Devices Market Development?

    A rising incidence of cancer is anticipated to fuel the expansion of the closed-system transfer devices market. This condition involves the unregulated proliferation of abnormal cells, capable of invading adjacent tissues and disseminating throughout the body via the blood and lymph systems. An uptick in cancer diagnoses can be attributed to several elements, including lifestyle choices, environmental influences, and heightened infection rates. Closed-system transfer devices are crucial instruments in cancer therapy, safeguarding healthcare professionals and patients from hazards linked to the manipulation and delivery of chemotherapy medications. Their deployment fosters a more secure healthcare setting and improved treatment results for individuals battling cancer. For example, projections released in February 2024 by the World Health Organization (WHO), a Switzerland-based intergovernmental body, indicate that by 2050, cancer cases are predicted to surpass 35 million. This figure signifies a 77% surge from the approximately 20 million cases forecast for 2022, underscoring the escalating global impact of cancer. Moreover, data from January 2023, provided by the US-based intergovernmental organization, the National Center for Biotechnology Information, revealed 1,958,310 new cancer cases in the United States, with 609,820 cancer deaths anticipated for 2023. Consequently, the rising prevalence of cancer acts as a key impetus for the closed-system transfer devices market.

    How Is Segmentation Applied In The Closed System Transfer Devices Market Segment Analysis?

    The closed system transfer devices market covered in this report is segmented –

    1) By Type: Needleless Systems, Membrane-To-Membrane Systems

    2) By Technology: Diaphragm-Based, Compartmentalized, Filtration

    3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems

    4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

    Subsegments:

    1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters

    2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

    What Trends Are Transforming The Closed System Transfer Devices Market?

    Major companies active in the closed system transfer devices (CSTD) market are focusing on creating innovative syringe units to bolster safety, refine user experience, reduce the chance of contamination, and comply with strict regulatory mandates within the healthcare industry. A syringe unit for full volume use describes a syringe specifically designed to dispense or deliver the complete volume of a liquid or medication it holds, without requiring any additional mixing or dilution. For instance, in October 2023, Equashield, a US-based medical device company, launched the EQUASHIELD Syringe Unit, which secured FDA clearance for full-volume use, thus enabling safer and more efficient handling of hazardous drugs. This inventive design prevents vapor from escaping and guards against plunger contamination, establishing it as a cost-effective solution for compounding and administering medications.

    Who Are The Companies Participating In The Closed System Transfer Devices Market Environment?

    Major companies operating in the closed system transfer devices market are Cardinal Health Inc., Becton Dickinson and Company, Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Aegis Medical Technologies, Epic Medical Pte Ltd., Smiths Medical

    Get The Full Closed System Transfer Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

    Which Region Holds The Highest Market Share In The Closed System Transfer Devices Market?

    North America was the largest region in the closed system transfer device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Closed System Transfer Devices Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp

    Browse Through More Reports Similar to the Global Closed System Transfer Devices Market 2026, By The Business Research Company

    White Biotechnology Market Report 2026

    https://www.thebusinessresearchcompany.com/report/white-biotechnology-global-market-report

    Pet Cloning Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pet-cloning-global-market-report

    Synthetic Biology Market Report 2026

    https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Closed System Transfer Devices Market Future Outlook Showing Growth Toward $2.17 Billion By 2030

    Closed System Transfer Devices Market Future Outlook Showing Growth Toward $2.17 Billion By 2030

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Expansion In Market Value Is Forecasted For The Closed System Transfer Devices Market Between 2026 And 2030?

    The market size for closed system transfer devices has seen rapid expansion in recent years. This market is forecast to increase from $1.18 billion in 2025 to $1.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.2%. The growth observed in the historical period is linked to the rising use of hazardous drugs in oncology, increased awareness of occupational exposure risks, the establishment of safety guidelines for drug handling, the expansion of hospital oncology services, and the growing adoption of chemotherapy infusion therapies.

    The market for closed system transfer devices is projected to experience swift expansion in the coming years. This market is anticipated to reach $2.18 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. The projected expansion during this period stems from factors such as more stringent regulatory enforcement regarding hazardous drug handling, an increase in cancer treatment volumes, a greater focus on adherence to workplace safety, the worldwide proliferation of oncology centers, and increased capital expenditure in hospital pharmacy safety infrastructure. Key trends expected during the forecast period encompass the increasing integration of closed drug handling systems in oncology, an elevated focus on protecting healthcare workers and minimizing their exposure, a growing inclination towards needleless closed transfer systems, the broader implementation of CSTD across hospital pharmacies, and the increasing standardization of protocols for handling hazardous drugs.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

    Which Key Drivers Are Affecting The Closed System Transfer Devices Market Development?

    A rising incidence of cancer is anticipated to fuel the expansion of the closed-system transfer devices market. This condition involves the unregulated proliferation of abnormal cells, capable of invading adjacent tissues and disseminating throughout the body via the blood and lymph systems. An uptick in cancer diagnoses can be attributed to several elements, including lifestyle choices, environmental influences, and heightened infection rates. Closed-system transfer devices are crucial instruments in cancer therapy, safeguarding healthcare professionals and patients from hazards linked to the manipulation and delivery of chemotherapy medications. Their deployment fosters a more secure healthcare setting and improved treatment results for individuals battling cancer. For example, projections released in February 2024 by the World Health Organization (WHO), a Switzerland-based intergovernmental body, indicate that by 2050, cancer cases are predicted to surpass 35 million. This figure signifies a 77% surge from the approximately 20 million cases forecast for 2022, underscoring the escalating global impact of cancer. Moreover, data from January 2023, provided by the US-based intergovernmental organization, the National Center for Biotechnology Information, revealed 1,958,310 new cancer cases in the United States, with 609,820 cancer deaths anticipated for 2023. Consequently, the rising prevalence of cancer acts as a key impetus for the closed-system transfer devices market.

    How Is Segmentation Applied In The Closed System Transfer Devices Market Segment Analysis?

    The closed system transfer devices market covered in this report is segmented –

    1) By Type: Needleless Systems, Membrane-To-Membrane Systems

    2) By Technology: Diaphragm-Based, Compartmentalized, Filtration

    3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems

    4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

    Subsegments:

    1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters

    2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

    What Trends Are Transforming The Closed System Transfer Devices Market?

    Major companies active in the closed system transfer devices (CSTD) market are focusing on creating innovative syringe units to bolster safety, refine user experience, reduce the chance of contamination, and comply with strict regulatory mandates within the healthcare industry. A syringe unit for full volume use describes a syringe specifically designed to dispense or deliver the complete volume of a liquid or medication it holds, without requiring any additional mixing or dilution. For instance, in October 2023, Equashield, a US-based medical device company, launched the EQUASHIELD Syringe Unit, which secured FDA clearance for full-volume use, thus enabling safer and more efficient handling of hazardous drugs. This inventive design prevents vapor from escaping and guards against plunger contamination, establishing it as a cost-effective solution for compounding and administering medications.

    Who Are The Companies Participating In The Closed System Transfer Devices Market Environment?

    Major companies operating in the closed system transfer devices market are Cardinal Health Inc., Becton Dickinson and Company, Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Aegis Medical Technologies, Epic Medical Pte Ltd., Smiths Medical

    Get The Full Closed System Transfer Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

    Which Region Holds The Highest Market Share In The Closed System Transfer Devices Market?

    North America was the largest region in the closed system transfer device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Closed System Transfer Devices Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp

    Browse Through More Reports Similar to the Global Closed System Transfer Devices Market 2026, By The Business Research Company

    White Biotechnology Market Report 2026

    https://www.thebusinessresearchcompany.com/report/white-biotechnology-global-market-report

    Pet Cloning Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pet-cloning-global-market-report

    Synthetic Biology Market Report 2026

    https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Closed System Transfer Devices Market Future Outlook Showing Growth Toward $2.17 Billion By 2030

    Closed System Transfer Devices Market Future Outlook Showing Growth Toward $2.17 Billion By 2030

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Expansion In Market Value Is Forecasted For The Closed System Transfer Devices Market Between 2026 And 2030?

    The market size for closed system transfer devices has seen rapid expansion in recent years. This market is forecast to increase from $1.18 billion in 2025 to $1.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.2%. The growth observed in the historical period is linked to the rising use of hazardous drugs in oncology, increased awareness of occupational exposure risks, the establishment of safety guidelines for drug handling, the expansion of hospital oncology services, and the growing adoption of chemotherapy infusion therapies.

    The market for closed system transfer devices is projected to experience swift expansion in the coming years. This market is anticipated to reach $2.18 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. The projected expansion during this period stems from factors such as more stringent regulatory enforcement regarding hazardous drug handling, an increase in cancer treatment volumes, a greater focus on adherence to workplace safety, the worldwide proliferation of oncology centers, and increased capital expenditure in hospital pharmacy safety infrastructure. Key trends expected during the forecast period encompass the increasing integration of closed drug handling systems in oncology, an elevated focus on protecting healthcare workers and minimizing their exposure, a growing inclination towards needleless closed transfer systems, the broader implementation of CSTD across hospital pharmacies, and the increasing standardization of protocols for handling hazardous drugs.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

    Which Key Drivers Are Affecting The Closed System Transfer Devices Market Development?

    A rising incidence of cancer is anticipated to fuel the expansion of the closed-system transfer devices market. This condition involves the unregulated proliferation of abnormal cells, capable of invading adjacent tissues and disseminating throughout the body via the blood and lymph systems. An uptick in cancer diagnoses can be attributed to several elements, including lifestyle choices, environmental influences, and heightened infection rates. Closed-system transfer devices are crucial instruments in cancer therapy, safeguarding healthcare professionals and patients from hazards linked to the manipulation and delivery of chemotherapy medications. Their deployment fosters a more secure healthcare setting and improved treatment results for individuals battling cancer. For example, projections released in February 2024 by the World Health Organization (WHO), a Switzerland-based intergovernmental body, indicate that by 2050, cancer cases are predicted to surpass 35 million. This figure signifies a 77% surge from the approximately 20 million cases forecast for 2022, underscoring the escalating global impact of cancer. Moreover, data from January 2023, provided by the US-based intergovernmental organization, the National Center for Biotechnology Information, revealed 1,958,310 new cancer cases in the United States, with 609,820 cancer deaths anticipated for 2023. Consequently, the rising prevalence of cancer acts as a key impetus for the closed-system transfer devices market.

    How Is Segmentation Applied In The Closed System Transfer Devices Market Segment Analysis?

    The closed system transfer devices market covered in this report is segmented –

    1) By Type: Needleless Systems, Membrane-To-Membrane Systems

    2) By Technology: Diaphragm-Based, Compartmentalized, Filtration

    3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems

    4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

    Subsegments:

    1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters

    2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

    What Trends Are Transforming The Closed System Transfer Devices Market?

    Major companies active in the closed system transfer devices (CSTD) market are focusing on creating innovative syringe units to bolster safety, refine user experience, reduce the chance of contamination, and comply with strict regulatory mandates within the healthcare industry. A syringe unit for full volume use describes a syringe specifically designed to dispense or deliver the complete volume of a liquid or medication it holds, without requiring any additional mixing or dilution. For instance, in October 2023, Equashield, a US-based medical device company, launched the EQUASHIELD Syringe Unit, which secured FDA clearance for full-volume use, thus enabling safer and more efficient handling of hazardous drugs. This inventive design prevents vapor from escaping and guards against plunger contamination, establishing it as a cost-effective solution for compounding and administering medications.

    Who Are The Companies Participating In The Closed System Transfer Devices Market Environment?

    Major companies operating in the closed system transfer devices market are Cardinal Health Inc., Becton Dickinson and Company, Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Aegis Medical Technologies, Epic Medical Pte Ltd., Smiths Medical

    Get The Full Closed System Transfer Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

    Which Region Holds The Highest Market Share In The Closed System Transfer Devices Market?

    North America was the largest region in the closed system transfer device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Closed System Transfer Devices Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp

    Browse Through More Reports Similar to the Global Closed System Transfer Devices Market 2026, By The Business Research Company

    White Biotechnology Market Report 2026

    https://www.thebusinessresearchcompany.com/report/white-biotechnology-global-market-report

    Pet Cloning Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pet-cloning-global-market-report

    Synthetic Biology Market Report 2026

    https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Closed System Transfer Devices Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

    Global Closed System Transfer Devices Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Will Be The Estimated Market Valuation Of The Closed System Transfer Devices Market By The End Of 2030?

    The market size for closed system transfer devices has experienced rapid expansion in recent years. It is anticipated to grow from $1.18 billion in 2025 to $1.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.2%. The historical increase can be ascribed to several factors, including the rising application of hazardous drugs in oncology, greater recognition of occupational exposure risks, the implementation of safety guidelines for drug management, the broadening of hospital oncology services, and the increasing uptake of chemotherapy infusion therapies.

    The closed system transfer devices market is poised for substantial expansion in the coming years. It is forecast to grow to $2.18 billion in 2030, achieving a compound annual growth rate (CAGR) of 12.6%. This projected growth is driven by stricter regulatory enforcement for hazardous drug handling, rising cancer treatment volumes, an increasing focus on workplace safety compliance, the global expansion of oncology centers, and heightened investment in hospital pharmacy safety infrastructure. Key trends during this period include the rising adoption of closed drug handling systems in oncology, an intensified focus on healthcare worker safety and exposure reduction, a growing preference for needleless closed transfer systems, the expansion of CSTD usage across hospital pharmacies, and increasing standardization of hazardous drug handling protocols.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

    Which Market Drivers Are Supporting The Expansion Of The Closed System Transfer Devices Market?

    The anticipated rise in cancer occurrences is projected to drive the expansion of the closed-system transfer devices market moving ahead. Cancer is defined as an illness marked by the unchecked multiplication of atypical cells, capable of invading adjacent tissues and migrating to other bodily regions via the circulatory and lymphatic systems. A surge in cancer incidents is attributed to multiple influences, including lifestyle choices, environmental contact, and a rise in infections. In cancer therapy, closed-system transfer devices serve as vital instruments, safeguarding both healthcare professionals and patients from hazards linked to managing and dispensing chemotherapy medications. Their application fosters a more secure healthcare setting and leads to improved treatment results for individuals afflicted with cancer. For example, data from February 2024 by the World Health Organization (WHO), a Switzerland-based intergovernmental organization, indicates that by 2050, cancer cases are predicted to surpass 35 million, marking a 77% surge from the 20 million cases estimated for 2022. This substantial escalation underscores the escalating global burden of cancer. Additionally, in January 2023, the National Center for Biotechnology Information, a US-based intergovernmental organization, reported 1,958,310 new cancer cases and a projected 609,820 cancer deaths in the United States for 2023. Consequently, the rising number of cancer incidents propels the closed system transfer devices market.

    Which Segment Classifications Shape The Closed System Transfer Devices Market?

    The closed system transfer devices market covered in this report is segmented –

    1) By Type: Needleless Systems, Membrane-To-Membrane Systems

    2) By Technology: Diaphragm-Based, Compartmentalized, Filtration

    3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems

    4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

    Subsegments:

    1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters

    2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

    How Are Trends Impacting The Closed System Transfer Devices Market?

    Major companies engaged in the closed system transfer devices (CSTD) market are prioritizing the development of innovative syringe units. These advancements aim to improve safety, enhance user experience, minimize contamination risks, and meet rigorous regulatory standards in the healthcare industry. A syringe unit designed for full volume use signifies a syringe engineered to dispense or administer its complete liquid or medication content without requiring further mixing or dilution. For example, in October 2023, Equashield, a US-based medical device company, launched the EQUASHIELD Syringe Unit. This unit has obtained FDA clearance for full-volume use, thereby enabling safer and more efficient handling of hazardous drugs. Its inventive design prevents vapor from escaping and guards against plunger contamination, making it an economical option for compounding and administering medications.

    Which Companies Are Expanding Their Footprint In The Closed System Transfer Devices Market?

    Major companies operating in the closed system transfer devices market are Cardinal Health Inc., Becton Dickinson and Company, Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Aegis Medical Technologies, Epic Medical Pte Ltd., Smiths Medical

    Read the full closed system transfer devices market report here:

    https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

    How Is The Closed System Transfer Devices Market Distributed Across Key Geographic Regions?

    North America was the largest region in the closed system transfer device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Closed System Transfer Devices Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp

    Browse Through More Reports Similar to the Global Closed System Transfer Devices Market 2026, By The Business Research Company

    White Biotechnology Market Report 2026

    https://www.thebusinessresearchcompany.com/report/white-biotechnology-global-market-report

    Pet Cloning Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pet-cloning-global-market-report

    Synthetic Biology Market Report 2026

    https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Closed System Transfer Devices Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

    Global Closed System Transfer Devices Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Will Be The Estimated Market Valuation Of The Closed System Transfer Devices Market By The End Of 2030?

    The market size for closed system transfer devices has experienced rapid expansion in recent years. It is anticipated to grow from $1.18 billion in 2025 to $1.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.2%. The historical increase can be ascribed to several factors, including the rising application of hazardous drugs in oncology, greater recognition of occupational exposure risks, the implementation of safety guidelines for drug management, the broadening of hospital oncology services, and the increasing uptake of chemotherapy infusion therapies.

    The closed system transfer devices market is poised for substantial expansion in the coming years. It is forecast to grow to $2.18 billion in 2030, achieving a compound annual growth rate (CAGR) of 12.6%. This projected growth is driven by stricter regulatory enforcement for hazardous drug handling, rising cancer treatment volumes, an increasing focus on workplace safety compliance, the global expansion of oncology centers, and heightened investment in hospital pharmacy safety infrastructure. Key trends during this period include the rising adoption of closed drug handling systems in oncology, an intensified focus on healthcare worker safety and exposure reduction, a growing preference for needleless closed transfer systems, the expansion of CSTD usage across hospital pharmacies, and increasing standardization of hazardous drug handling protocols.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

    Which Market Drivers Are Supporting The Expansion Of The Closed System Transfer Devices Market?

    The anticipated rise in cancer occurrences is projected to drive the expansion of the closed-system transfer devices market moving ahead. Cancer is defined as an illness marked by the unchecked multiplication of atypical cells, capable of invading adjacent tissues and migrating to other bodily regions via the circulatory and lymphatic systems. A surge in cancer incidents is attributed to multiple influences, including lifestyle choices, environmental contact, and a rise in infections. In cancer therapy, closed-system transfer devices serve as vital instruments, safeguarding both healthcare professionals and patients from hazards linked to managing and dispensing chemotherapy medications. Their application fosters a more secure healthcare setting and leads to improved treatment results for individuals afflicted with cancer. For example, data from February 2024 by the World Health Organization (WHO), a Switzerland-based intergovernmental organization, indicates that by 2050, cancer cases are predicted to surpass 35 million, marking a 77% surge from the 20 million cases estimated for 2022. This substantial escalation underscores the escalating global burden of cancer. Additionally, in January 2023, the National Center for Biotechnology Information, a US-based intergovernmental organization, reported 1,958,310 new cancer cases and a projected 609,820 cancer deaths in the United States for 2023. Consequently, the rising number of cancer incidents propels the closed system transfer devices market.

    Which Segment Classifications Shape The Closed System Transfer Devices Market?

    The closed system transfer devices market covered in this report is segmented –

    1) By Type: Needleless Systems, Membrane-To-Membrane Systems

    2) By Technology: Diaphragm-Based, Compartmentalized, Filtration

    3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems

    4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

    Subsegments:

    1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters

    2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

    How Are Trends Impacting The Closed System Transfer Devices Market?

    Major companies engaged in the closed system transfer devices (CSTD) market are prioritizing the development of innovative syringe units. These advancements aim to improve safety, enhance user experience, minimize contamination risks, and meet rigorous regulatory standards in the healthcare industry. A syringe unit designed for full volume use signifies a syringe engineered to dispense or administer its complete liquid or medication content without requiring further mixing or dilution. For example, in October 2023, Equashield, a US-based medical device company, launched the EQUASHIELD Syringe Unit. This unit has obtained FDA clearance for full-volume use, thereby enabling safer and more efficient handling of hazardous drugs. Its inventive design prevents vapor from escaping and guards against plunger contamination, making it an economical option for compounding and administering medications.

    Which Companies Are Expanding Their Footprint In The Closed System Transfer Devices Market?

    Major companies operating in the closed system transfer devices market are Cardinal Health Inc., Becton Dickinson and Company, Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Aegis Medical Technologies, Epic Medical Pte Ltd., Smiths Medical

    Read the full closed system transfer devices market report here:

    https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

    How Is The Closed System Transfer Devices Market Distributed Across Key Geographic Regions?

    North America was the largest region in the closed system transfer device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Closed System Transfer Devices Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp

    Browse Through More Reports Similar to the Global Closed System Transfer Devices Market 2026, By The Business Research Company

    White Biotechnology Market Report 2026

    https://www.thebusinessresearchcompany.com/report/white-biotechnology-global-market-report

    Pet Cloning Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pet-cloning-global-market-report

    Synthetic Biology Market Report 2026

    https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Closed System Transfer Devices Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

    Global Closed System Transfer Devices Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Will Be The Estimated Market Valuation Of The Closed System Transfer Devices Market By The End Of 2030?

    The market size for closed system transfer devices has experienced rapid expansion in recent years. It is anticipated to grow from $1.18 billion in 2025 to $1.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.2%. The historical increase can be ascribed to several factors, including the rising application of hazardous drugs in oncology, greater recognition of occupational exposure risks, the implementation of safety guidelines for drug management, the broadening of hospital oncology services, and the increasing uptake of chemotherapy infusion therapies.

    The closed system transfer devices market is poised for substantial expansion in the coming years. It is forecast to grow to $2.18 billion in 2030, achieving a compound annual growth rate (CAGR) of 12.6%. This projected growth is driven by stricter regulatory enforcement for hazardous drug handling, rising cancer treatment volumes, an increasing focus on workplace safety compliance, the global expansion of oncology centers, and heightened investment in hospital pharmacy safety infrastructure. Key trends during this period include the rising adoption of closed drug handling systems in oncology, an intensified focus on healthcare worker safety and exposure reduction, a growing preference for needleless closed transfer systems, the expansion of CSTD usage across hospital pharmacies, and increasing standardization of hazardous drug handling protocols.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

    Which Market Drivers Are Supporting The Expansion Of The Closed System Transfer Devices Market?

    The anticipated rise in cancer occurrences is projected to drive the expansion of the closed-system transfer devices market moving ahead. Cancer is defined as an illness marked by the unchecked multiplication of atypical cells, capable of invading adjacent tissues and migrating to other bodily regions via the circulatory and lymphatic systems. A surge in cancer incidents is attributed to multiple influences, including lifestyle choices, environmental contact, and a rise in infections. In cancer therapy, closed-system transfer devices serve as vital instruments, safeguarding both healthcare professionals and patients from hazards linked to managing and dispensing chemotherapy medications. Their application fosters a more secure healthcare setting and leads to improved treatment results for individuals afflicted with cancer. For example, data from February 2024 by the World Health Organization (WHO), a Switzerland-based intergovernmental organization, indicates that by 2050, cancer cases are predicted to surpass 35 million, marking a 77% surge from the 20 million cases estimated for 2022. This substantial escalation underscores the escalating global burden of cancer. Additionally, in January 2023, the National Center for Biotechnology Information, a US-based intergovernmental organization, reported 1,958,310 new cancer cases and a projected 609,820 cancer deaths in the United States for 2023. Consequently, the rising number of cancer incidents propels the closed system transfer devices market.

    Which Segment Classifications Shape The Closed System Transfer Devices Market?

    The closed system transfer devices market covered in this report is segmented –

    1) By Type: Needleless Systems, Membrane-To-Membrane Systems

    2) By Technology: Diaphragm-Based, Compartmentalized, Filtration

    3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems

    4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

    Subsegments:

    1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters

    2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

    How Are Trends Impacting The Closed System Transfer Devices Market?

    Major companies engaged in the closed system transfer devices (CSTD) market are prioritizing the development of innovative syringe units. These advancements aim to improve safety, enhance user experience, minimize contamination risks, and meet rigorous regulatory standards in the healthcare industry. A syringe unit designed for full volume use signifies a syringe engineered to dispense or administer its complete liquid or medication content without requiring further mixing or dilution. For example, in October 2023, Equashield, a US-based medical device company, launched the EQUASHIELD Syringe Unit. This unit has obtained FDA clearance for full-volume use, thereby enabling safer and more efficient handling of hazardous drugs. Its inventive design prevents vapor from escaping and guards against plunger contamination, making it an economical option for compounding and administering medications.

    Which Companies Are Expanding Their Footprint In The Closed System Transfer Devices Market?

    Major companies operating in the closed system transfer devices market are Cardinal Health Inc., Becton Dickinson and Company, Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Aegis Medical Technologies, Epic Medical Pte Ltd., Smiths Medical

    Read the full closed system transfer devices market report here:

    https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

    How Is The Closed System Transfer Devices Market Distributed Across Key Geographic Regions?

    North America was the largest region in the closed system transfer device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Closed System Transfer Devices Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp

    Browse Through More Reports Similar to the Global Closed System Transfer Devices Market 2026, By The Business Research Company

    White Biotechnology Market Report 2026

    https://www.thebusinessresearchcompany.com/report/white-biotechnology-global-market-report

    Pet Cloning Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pet-cloning-global-market-report

    Synthetic Biology Market Report 2026

    https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Closed System Transfer Devices Market Trends and Insights: Global Forecast to 2030

    Closed System Transfer Devices Market Trends and Insights: Global Forecast to 2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

    What long-term size projections exist for the Closed System Transfer Devices Market covering 2026–2035?

    The market for closed system transfer devices has experienced rapid growth in recent years. This market is anticipated to expand from $1.18 billion in 2025 to $1.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.2%. Historically, this expansion has been propelled by the escalating use of hazardous drugs in oncology, increasing recognition of occupational exposure risks, the establishment of safety guidelines for drug handling, the expansion of hospital oncology services, and the rising adoption of chemotherapy infusion therapies.

    The market for closed system transfer devices is projected to experience substantial expansion in the coming years. This market is set to reach a value of $2.18 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. Several factors are expected to fuel this growth during the forecast period, including more stringent regulatory enforcement regarding hazardous drug handling, an increase in cancer treatment volumes, a greater focus on workplace safety compliance, the global expansion of oncology centers, and increased investment in hospital pharmacy safety infrastructure. Key trends anticipated during this period involve the growing adoption of closed drug handling systems in oncology, an intensified focus on ensuring healthcare worker safety and minimizing exposure, a rising preference for needleless closed transfer systems, the broader integration of cstd usage across hospital pharmacies, and an increase in the standardization of hazardous drug handling protocols.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

    Which Drivers Are Impacting The Competitive Landscape Of The Closed System Transfer Devices Market?

    The anticipated expansion of the closed-system transfer devices market is largely driven by the rising incidence of cancer. Cancer, a condition defined by the unrestrained proliferation of atypical cells, has the capacity to infiltrate adjacent tissues and disseminate throughout the body via the bloodstream and lymphatic systems. Various elements, including lifestyle choices, environmental exposures, and heightened infection rates, contribute to the escalating number of cancer cases. In cancer therapy, closed-system transfer devices serve as crucial instruments, safeguarding both medical personnel and patients from the hazards involved in managing and delivering chemotherapy medications. Their implementation fosters a more secure healthcare setting and leads to improved treatment results for individuals battling cancer. For example, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported in February 2024 that cancer cases are projected to surpass 35 million by 2050, marking a significant 77% increase from the approximately 20 million cases estimated for 2022. This substantial increase underscores the intensifying global impact of cancer. Moreover, data from January 2023 by the National Center for Biotechnology Information, a US-based intergovernmental organization, indicated 1,958,310 new cancer cases in the United States, with 609,820 cancer deaths anticipated for 2023. Consequently, the rising number of cancer diagnoses is a key impetus for the closed system transfer devices market.

    What Segments Are Identified Within The Structure Of The Closed System Transfer Devices Market?

    The closed system transfer devices market covered in this report is segmented –

    1) By Type: Needleless Systems, Membrane-To-Membrane Systems

    2) By Technology: Diaphragm-Based, Compartmentalized, Filtration

    3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems

    4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

    Subsegments:

    1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters

    2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

    Which Innovation Trends Are Advancing Developments Within The Closed System Transfer Devices Market?

    Companies operating within the closed system transfer devices (CSTD) market are actively concentrating on developing advanced syringe units to boost safety, improve user experience, reduce contamination risks, and adhere to stringent regulatory standards in the healthcare industry. A syringe unit for full volume use refers to a syringe specifically designed to deliver the complete volume of its contained liquid or medication without requiring additional mixing or dilution. As an example, in October 2023, Equashield, a US-based medical device company, introduced the EQUASHIELD Syringe Unit, which has secured FDA clearance for full-volume use, thereby enabling safer and more efficient handling of hazardous drugs. This innovative design effectively prevents vapor from escaping and avoids plunger contamination, establishing it as a cost-effective solution for compounding and administering medications.

    Which Major Firms Are Strengthening Their Position In The Closed System Transfer Devices Market?

    Major companies operating in the closed system transfer devices market are Cardinal Health Inc., Becton Dickinson and Company, Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Aegis Medical Technologies, Epic Medical Pte Ltd., Smiths Medical

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

    Which Region Is Anticipated To See The Fastest Growth In The Closed System Transfer Devices Market?

    North America was the largest region in the closed system transfer device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Closed System Transfer Devices Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp

    Browse Through More Reports Similar to the Global Closed System Transfer Devices Market 2026, By The Business Research Company

    White Biotechnology Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/white-biotechnology-global-market-report

    Pet Cloning Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pet-cloning-global-market-report

    Synthetic Biology Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

  • Closed System Transfer Devices Market Expansion to $1.96 Billion by 2029: Key Drivers and Trends

    Closed System Transfer Devices Market Expansion to $1.96 Billion by 2029: Key Drivers and Trends

    Uncover key drivers, emerging technologies, and competitive movements shaping the closed system transfer devices market from 2025–2034 with trusted insights from The Business Research Company

    What Is The Base Market Size For The Closed System Transfer Devices Market Today And What Will It Reach By 2029?

    The closed system transfer devices market size has shown substantial growth in recent years. It is projected to expand from $1.04 billion in 2024 to $1.18 billion in 2025, maintaining a compound annual growth rate (CAGR) of 13.7%. This historical growth is attributable to several factors, including an increase in oncology drug approvals, a greater focus on occupational safety, the rising need to prevent needlestick injuries and exposure to hazardous drugs, heightened awareness regarding the potential dangers of cytotoxic drug exposure, and an expanding chemotherapy patient population.

    The market size for closed system transfer devices is projected to experience substantial expansion in the coming years. It is anticipated to grow to $1.96 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 13.4%. This growth during the forecast period is attributable to the increasing prevalence of cancer, a heightened necessity for monitoring compliance in the safe management of injurious drugs, increasing understanding regarding the application of closed system transfer devices, the rising adoption of CSTDS for transporting hazardous medications, and an escalating quantity of drug sanctions for cancer. Prominent trends for the forecast period include the introduction of new products focusing on safety, the development of digital platforms and user-friendly devices, intensive research and development activities, ongoing technological advancements, and the widespread implementation of membrane-to-membrane systems.

    Access A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

    What Factors Are Boosting The Closed System Transfer Devices Market?

    The future expansion of the closed-system transfer devices market is anticipated to be driven by the rising incidence of cancer. Cancer is defined as an illness marked by the unchecked multiplication of abnormal cells capable of infiltrating adjacent tissues and disseminating throughout the body via the blood and lymph networks. The uptick in cancer diagnoses is attributable to multiple elements, including lifestyle choices, environmental influences, and heightened susceptibility to infections. In cancer therapy, closed-system transfer devices play a crucial role by safeguarding both medical personnel and patients from hazards linked to the manipulation and delivery of chemotherapy medications. Their application fosters a more secure healthcare setting and improved therapeutic results for individuals battling cancer. For example, the World Health Organization (WHO), an intergovernmental body based in Switzerland, reported in February 2024 that cancer cases are projected to surpass 35 million by 2050, signifying a 77% surge from the approximate 20 million cases forecasted for 2022. This substantial increase underscores the escalating global impact of cancer. Moreover, data from the National Center for Biotechnology Information, a US-based intergovernmental organization, indicated in January 2023 that the United States saw 1,958,310 new cancer cases, with 609,820 cancer fatalities anticipated for 2023. Consequently, the expanding number of cancer diagnoses fuels the demand for the closed-system transfer devices market.

    How Is The Closed System Transfer Devices Market Categorized By Application, Type, And Region?

    The closed system transfer devicesmarket covered in this report is segmented –

    1) By Type: Needleless Systems, Membrane-To-Membrane Systems

    2) By Technology: Diaphragm-Based, Compartmentalized, Filtration

    3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems

    4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

    Subsegments:

    1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters

    2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

    How Are Technological Trends Affecting The Closed System Transfer Devices Market Growth?

    Leading companies active in the closed system transfer devices (CSTD) market are prioritizing the development of advanced syringe units. These initiatives aim to enhance safety, improve user experience, minimize contamination risks, and comply with rigorous regulatory standards within the healthcare sector. A syringe unit designated for full volume use refers to a syringe engineered to deliver or administer the complete quantity of liquid or medication it contains, without requiring additional mixing or dilution. For instance, in October 2023, Equashield, a US-based medical device company, launched the EQUASHIELD Syringe Unit. This product has secured FDA clearance for full-volume applications, facilitating safer and more efficient handling of hazardous drugs. This innovative design prevents vapor escape and plunger contamination, making it an economical choice for both compounding and administering medications.

    Who Are The Global Leaders Steering The Closed System Transfer Devices Market Forward?

    Major companies operating in the closed system transfer devices market are Cardinal Health Inc., Becton Dickinson and Company, Baxter International Inc., Corning Incorporated, B Braun Melsungen AG, Grifols SA, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Carmel Pharma AB, Aegis Medical Technologies, Epic Medical Pte Ltd., Smiths Medical

    Download The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

    Which Region Is Projected To Achieve The Fastest Growth In The Closed System Transfer Devices Market?

    North America was the largest region in the closed system transfer device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Get A Report Customized For You Here:

    https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp

    Browse Through More Reports Similar to the Global Closed System Transfer Devices Market 2025, By The Business Research Company

    Ophthalmic Devices Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report

    Cardiovascular Devices Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

    Orthopedic Devices Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/orthopedic-devices-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model